From IND to BLA: The Biologics CMC Decisions That Determine Regulatory Success – Part 2
Biologics manufacturing success is built—not salvaged—from day one. Overlook CMC fundamentals, and you’re architecting your own failure.
From IND to BLA: The Biologics CMC Decisions That Determine Regulatory Success – Part 1
How solid is your CMC foundation—and what happens if it cracks under pressure?
Cyanobacteria Biomanufacturing: Achieving Carbon-Neutral Production at Lower Cost Than Fermentation – Part 2
If biotech had a “cheat code” for sustainable manufacturing, what would it look like?
Cyanobacteria Biomanufacturing: Achieving Carbon-Neutral Production at Lower Cost Than Fermentation – Part 1
What if the ocean’s tiniest inhabitants held the secret to decarbonizing the entire chemicals industry?
Media-Based Glycan Engineering for Biosimilars: Your Rapid Implementation Guide
When raffinose works, when it doesn’t, and a 3-experiment protocol to validate it for your process in 8 weeks.
Media-Based Glycan Engineering for Biosimilars: Achieving Reference Product Match
Why pistachios sabotaged cyclists’ performance — and the raffinose mechanism behind it.
Mastering Radiopharmaceutical Development: Preclinical Model Selection for Clinical Success – Part 2
Hard-to-treat cancers like pancreatic ductal adenocarcinoma have defied conventional therapies for decades.
Mastering Radiopharmaceutical Development: Preclinical Model Selection for Clinical Success – Part 1
Imagine treating cancer with something as precise as a guided missile—radioactive payloads delivered only where they’re needed most.
From Cultivated Meat to Chocolate: Rethinking Cellular Agriculture Scale-Up – Part 2
Our food systems face a monumental challenge: by 2050, the global population could reach 10 billion, demanding at least 60% more food than we produce today.
From Cultivated Meat to Chocolate: Rethinking Cellular Agriculture Scale-Up – Part 1
What if your daily chocolate or coffee could be brewed without farms—or deforestation—but straight from a bioreactor?